(Reuters) -India’s Syngene International on Monday said it has acquired its first biologics facility in the United States ...
Biocon Biologics, one of India's leading biologic drug manufacturers, announced on Friday the results of a Phase-3 study on a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback